The chemotherapeutic response of a murine (VM) model of human glioma.
Using a cell line derived from the VM spontaneous murine astrocytoma, a reliable in vitro-in vivo model of human malignant glioma has been developed. In this paper we examine the effects of cytotoxic drugs with known activity against other animal brain tumour models and human disease on the in vivo VM model. The drugs BCNU, CCNU and vincristine produced significant volume reduction in tumours growing at a subcutaneous location in syngeneic animals. Procarbazine was ineffective. Similarly, BCNU, CCNU and vincristine produced small but statistically significant increases in survival of VM mice bearing the intracerebral tumour, but procarbazine was again ineffective. The modest, but significant, response of the VM model to the nitrosoureas mimics the human situation more closely than previously described animal models.
Bradford
R
R
Gough-Cooper Department of Neurological Surgery, Institute of Neurology, London, UK.
Darling
J L
JL
Thomas
D G
DG
D000818:Animals; D001254:Astrocytoma / Q000188:drug therapy*; D001932:Brain Neoplasms / Q000188:drug therapy; D002330:Carmustine / Q000627:therapeutic use; D004195:Disease Models, Animal; D008130:Lomustine / Q000627:therapeutic use; D051379:Mice; D008815:Mice, Inbred Strains; D011344:Procarbazine / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy; D014750:Vincristine / Q000627:therapeutic use
D011344:Procarbazine; D014750:Vincristine; D008130:Lomustine; D002330:Carmustine